z-logo
Premium
Evidence of an interaction between nifedipine and nafcillin in humans
Author(s) -
Lang C. C.,
Jamal S. K.,
Mohamed Z.,
Mustafa M. R.,
Mustafa A. M.,
Lee T. C.
Publication year - 2003
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1046/j.1365-2125.2003.01789.x
Subject(s) - nifedipine , nafcillin , pharmacology , chemistry , crossover study , pharmacokinetics , placebo , cyp3a4 , drug interaction , medicine , cytochrome p450 , metabolism , biochemistry , calcium , antibiotics , alternative medicine , organic chemistry , pathology , penicillin
Aims  Nafcillin (Wyeth Laboratories, Philadelphia, PA, USA) has been reported to induce the metabolism of cyclosporin and warfarin, which are known substrates of cytochrome P‐450 (CYP). However, there has not been any report to date on its possible interaction with nifedipine, an index substrate of the enzyme, CYP3A4. Methods  Nine healthy normotensive subjects participated in this randomized placebo‐controlled two‐way crossover study examining the effects of 5 days’ pretreatment of nafcillin 500 mg or placebo four times daily on the pharmacokinetics of an oral dose of nifedipine 10 mg. Plasma nifedipine concentrations were measured by gas chromatography–mass spectro. Results  The area under the plasma nifedipine concentration–time curve (AUC 0–α ) in nafcillin‐pretreated subjects (80.9 ± 32.9 µg l −1  h −1 ) was significantly decreased compared with subjects who received only nifedipine (216.4 ± 93.2 µg l −1  h −1 ) ( P  < 0.001). Total plasma clearance of nifedipine (CL/F) was significantly increased with nafcillin pretreatment (138.5 ± 42.0 l h −1 vs 56.5 ± 32.0 l h −1 ) ( P  < 0.002). Conclusions  The results show that nafcillin pretreatment markedly increased the clearance of nifedipine and suggest that nafcillin is a potent inducer of CYP enzyme.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here